Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Operating Expenses | 3,854 | 2,571 | 1,801 | 1,898 | 1,880 |
| Operating Income | -3,854 | -2,571 | -1,801 | -1,898 | -1,880 |
| Interest Expense | 209 | 209 | 262 | 176 | 173 |
| Other Income | 35 | 57 | -32 | 57 | 152 |
| Pre-tax Income | -4,028 | -2,723 | -2,095 | -2,018 | -1,901 |
| Net Income Continuous | -4,028 | -2,723 | -2,095 | -2,018 | -1,901 |
| Net Income | $-4,028 | $-2,723 | $-2,095 | $-2,018 | $-1,901 |
| EPS Basic Total Ops | -3,050.00 | -2,150.00 | -3,600.00 | -1,500.00 | -1,500.00 |
| EPS Basic Continuous Ops | -2,952.61 | -2,061.86 | -1,449.74 | -1,553.52 | -1,463.93 |
| EPS Diluted Total Ops | -3,050.00 | -2,150.00 | -3,600.00 | -1,500.00 | -1,500.00 |
| EPS Diluted Continuous Ops | -2,952.61 | -2,061.86 | -1,449.74 | -1,553.52 | -1,463.93 |
| EBITDA(a) | $-3,798 | $-2,513 | $-1,770 | $-1,815 | $-1,825 |